81 related articles for article (PubMed ID: 14708129)
21. Risperidone for psychosis of Alzheimer's disease and mixed dementia: results of a double-blind, placebo-controlled trial.
Brodaty H; Ames D; Snowdon J; Woodward M; Kirwan J; Clarnette R; Lee E; Greenspan A
Int J Geriatr Psychiatry; 2005 Dec; 20(12):1153-7. PubMed ID: 16315159
[TBL] [Abstract][Full Text] [Related]
22. Risperidone long-acting injection in practice - more questions than answers?
Taylor D
Acta Psychiatr Scand; 2006 Jul; 114(1):1-2. PubMed ID: 16774654
[No Abstract] [Full Text] [Related]
23. Priapism associated with the switch from oral to injectable risperidone.
Kirshner A; Davis RR
J Clin Psychopharmacol; 2006 Dec; 26(6):626-8. PubMed ID: 17110819
[TBL] [Abstract][Full Text] [Related]
24. [Neuroleptic malignant syndrome in users of risperidone].
van Bemmel T; Westendorp RG
Ned Tijdschr Geneeskd; 2005 Mar; 149(11):608; author reply 608. PubMed ID: 15799646
[No Abstract] [Full Text] [Related]
25. [Neuroleptic malignant syndrome in users of risperidone].
Vorel SK; Bos F; Vorel-Havelkova E; Brombacher PJ
Ned Tijdschr Geneeskd; 2005 Jan; 149(3):159-60; author reply 160. PubMed ID: 15693596
[No Abstract] [Full Text] [Related]
26. Early onset of treatment effects with oral risperidone.
Raedler TJ; Schreiner A; Naber D; Wiedemann K
BMC Psychiatry; 2007 Jan; 7():4. PubMed ID: 17239237
[TBL] [Abstract][Full Text] [Related]
27. [Neuroleptic malignant syndrome in users of risperidone].
van Waarde JA; Kuiper J; Verwey B
Ned Tijdschr Geneeskd; 2005 Jan; 149(3):156-7; author reply 157. PubMed ID: 15693593
[No Abstract] [Full Text] [Related]
28. [Neuroleptic malignant syndrome in users of risperidone].
Kroon JG
Ned Tijdschr Geneeskd; 2005 Jan; 149(3):157-8; author reply 158. PubMed ID: 15693594
[No Abstract] [Full Text] [Related]
29. Long-acting risperidone-induced periorbital edema.
Pelizza L
J Clin Psychopharmacol; 2008 Dec; 28(6):709-10. PubMed ID: 19011446
[No Abstract] [Full Text] [Related]
30. Leukopenia during therapy with risperidone long-acting injectable: two case reports.
Uzun S; Kozumplik O; Jakovljević M; Folnegović-Smalc V
J Clin Psychopharmacol; 2008 Dec; 28(6):713-4. PubMed ID: 19011449
[No Abstract] [Full Text] [Related]
31. [Neuroleptic malignant syndrome in users of risperidone].
Bonte-Mineur F; Geerlings CJ; Rietveld AP
Ned Tijdschr Geneeskd; 2005 Jan; 149(3):158-9; author reply 159. PubMed ID: 15693595
[No Abstract] [Full Text] [Related]
32. Psychiatric treatment of patients predisposed to priapism induced by quetapine, trazadone and risperidone: a case report.
Rosenberg I; Aniskin D; Bernay L
Gen Hosp Psychiatry; 2009; 31(1):98. PubMed ID: 19134518
[No Abstract] [Full Text] [Related]
33. Hypothermia in a patient receiving risperidone and paroxetine.
Al Chekakie MO; Ketz JM; Whinney CM
J Clin Psychopharmacol; 2006 Jun; 26(3):332-3. PubMed ID: 16702902
[No Abstract] [Full Text] [Related]
34. [Treatment of behavioral disorders in dementia with risperidone in psychogeriatric out-patients].
Kurz A; Delius-Stute H; Rettig K; Schwalen S
MMW Fortschr Med; 2003 Oct; 145 Suppl 3():89-95. PubMed ID: 15490773
[TBL] [Abstract][Full Text] [Related]
35. Mortality in elderly dementia patients treated with risperidone.
Haupt M; Cruz-Jentoft A; Jeste D
J Clin Psychopharmacol; 2006 Dec; 26(6):566-70. PubMed ID: 17110812
[TBL] [Abstract][Full Text] [Related]
36. Risperidone (Risperdal): increased rate of cerebrovascular events in dementia trials.
Wooltorton E
CMAJ; 2002 Nov; 167(11):1269-70. PubMed ID: 12451085
[No Abstract] [Full Text] [Related]
37. Catatonia and mild neuroleptic malignant syndrome after initiation of long-acting injectable risperidone: case report.
Mall GD; Hake L; Benjamin AB; Adityanjee A
J Clin Psychopharmacol; 2008 Oct; 28(5):572-3. PubMed ID: 18794658
[No Abstract] [Full Text] [Related]
38. [Antipsychotic agents--not to patients with dementia?].
Arsland D; Engedal K
Tidsskr Nor Laegeforen; 1999 Jan; 119(2):263-4. PubMed ID: 10081363
[No Abstract] [Full Text] [Related]
39. Follow-up of a pregnancy with risperidone microspheres.
Dabbert D; Heinze M
Pharmacopsychiatry; 2006 Nov; 39(6):235. PubMed ID: 17124649
[TBL] [Abstract][Full Text] [Related]
40. Injectable sustained-release risperidone: recurrence of delirium and treatment failure.
Prescrire Int; 2006 Oct; 15(85):183. PubMed ID: 17131515
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
